We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clearstar Inc. | LSE:CLSU | London | Ordinary Share | KYG2294M1134 | ORD USD0.0001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 39.50 | 39.00 | 40.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2019 08:15 | positive update on FY18: sales +13% and 95% from recurring tests. Group looks well set to continue expanding share and ED upgrades both forecasts and Fair Value to well above share price. New research note freely available here: | edmonda | |
20/11/2018 08:33 | more contract wins today, including a first in the targeted professional services segment. Updated research note, with fair value seen at over twice current market cap, freely available here: | edmonda | |
16/10/2018 13:46 | after today's news of selection by Virtual Badge of ClearStar's background screening, updated research out looking at the cross-selling synergies arising, plus lower share rating after recent stockmarket wobble. Free access here: | edmonda | |
17/9/2018 08:12 | Good progress at H1 stage: revs $9.9m +11%, positive adj EBITDA, net cash of $1.2m plus $5m revolver available. New ED research note with raised fair value freely accessible here: | edmonda | |
18/7/2018 08:30 | Encouraging trading update ahead of Sept results. Fair value adjusted in latest research note here: | edmonda | |
20/6/2018 08:45 | more good news announced today as giant Abbot Labs integrates its ClearMD mobile drug testing solution. Implications explained in latest research note, freely available here: | edmonda | |
22/5/2018 15:28 | Positive trading update, and analyst valuation reassessed in new report: freely available here: | edmonda | |
02/5/2018 08:13 | Good to see further leveraging of co's tech USPs over another platform: strategic partnership announced today with Veritas Prime. Potential explained here: | edmonda | |
20/4/2018 17:51 | Encouraging too, to see the Chairman picking up another line of stock "ClearStar (AIM: CLSU), the technology and service provider to the background check industry, announces that Barney Quinn, Non-executive Chairman of the Company, purchased 33,660 ordinary shares of $0.0001 in the Company ("Ordinary Shares") on 18 April 2018 at a price of 44 pence per Ordinary Share. Following this purchase, Mr. Quinn holds 278,215 Ordinary Shares, representing approximately 0.77% of the issued share capital of the Company." | brummy_git | |
20/4/2018 17:34 | 20 min video of CEO and CFO explaining the exciting growth in background screening and ClearStar's USPs here: | edmonda | |
17/4/2018 08:24 | Encouraging FY results out today with revs $17.8m +11% and CEO seeing 2018 as 'pivotal year'. Updated ED research note now out with forecasts and highlighting valuation disparities - freely available here: | edmonda | |
12/7/2017 09:31 | ClearStar Inc write up by Paul Hill at Equity Development: Don’t you just love ‘Tech’? Churning out irresistible growth rates, profit margins and cashflows, allied to robust visibility and high client retention. A compelling mix. The only problem is that many others do as well, pushing valuations to often nose-bleed levels. However, what if it was possible to find a company, expanding at >10% pa (see below), yet trading at a mere 1.1x EV/sales vs 2x-4x for the wider sector. Interested? I was too on coming across ClearStar Inc (AIM: CLSU). A little-known £16m market cap stock, providing automated job screening and alcohol/drug testing services. Areas enjoying buoyant demand from the rise of the ‘gig’ economy (Uber/Deliveroo), government clampdowns on illegal workers and ongoing healthy employment levels. In fact, I was so impressed that I snapped up a 3.6% stake earlier this year (RNS)... | edmonda |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions